Protective effect of enalapril on vascular reactivity of the rat aorta

Vascular Pharmacology

Volumn 40, Issue 6, 2004, Pages 301-307

  Baluchnejadmojarad, Tourandokht ^a   Roghani, Mehrdad ^b   Imani, Alireza ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Aortic reactivity; Diabetes mellitus; Enalapril; Rat; Streptozotocin

Indexed keywords

ACETYLCHOLINE; ENALAPRIL; ISOSORBIDE 2 NITRATE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; ENDOTHELIUM, VASCULAR; ISOSORBIDE DINITRATE; MALE; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 1842581903     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2004.02.003     Document Type: Article

References (34)

1. 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovas. Pharmacol. 16:1990;239-248.
2. Auch-Schwelk W., Duske E., Claus M., Graf K., Grafe M., Fleck E. Endothelium-mediated vasodilation during ACE inhibition. Eur. Heart J. 16:1995;59-65.
3. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1992;405-412.
4. Chang K.C., Chung S.Y., Chong W.S., Suh J.S., Kim S.H., Noh H.K., Seong B.W., Ko H.J., Chun K.W. Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats. J. Pharmacol. Exp. Ther. 266:1993;992-1000.
5. Chobanian A.V., Haudenschild C.C., Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 15:1990;327-331.
6. Chopra M., Beswick H., Clapperton M., Dargie H.J., Smith W.E., Mc Murray J. Antioxidant effects of angiotensin-converting (ACE) inhibitors: free radical and antioxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J. Cardiovasc. Pharmacol. 19:1992;330-340.
7. Duarte J., Martinez A., Bermejo A., Vera B., Gamez M.J., Cabo P., Zarzuelo A. Cardiovascular effects of captopril and enalapril in obese Zucker rats. Eur. J. Pharmacol. 365:1999;225-232.
8. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:1996;257-267.
9. Gohlke P., Unger T. Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin. Am. J. Cardiol. 76:1995;41E-45E.
10. Hamdan A.D., Quist W.C., Gagne J.B., Feener E.P. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta. Circulation. 93:1996;1073-1078.
11. Hoffmann G., Pietsch R., Gobel B.O., Weisser B., Bonner G., Vetter H., Dusing R. Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism. Eur. J. Pharmacol. 178:1990;79-83.
12. Itoh Y., Imamura S., Yamamoto K., Ono Y., Nagata M., Kobayashi T., Kato T., Tomita M., Nakai A., Itoh M., Nagasaka A. Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate. J. Endocrinol. 175:2002;233-239.
13. Kalender B., Ozturk M., Tuncdemir M., Uysal O., Dagistanli F.K., Yegenaga I., Erek E. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem. 104:2002;123-130.
14. Kamata K., Miyata N., Kasuya Y. Impairment of endothelium-dependent relaxation and changes on levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97:1989;614-618.
15. Karasu C., Altan V.M. The role of endothelial cells on the alterations in vascular reactivity induced by insulin-dependent diabetes mellitus: effects of insulin treatment. Gen. Pharmacol. 24:1993;743-755.
16. Kedziora-Kornatowska K.Z., Luciak M., Paszkowski J. Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life. 49:2000;303-307.
17. Kikta D.C., Fregly M.J. Effect of in vitro administration of captopril on vascular reactivity of rat aorta. Hypertension. 4:1982;118-124.
18. Kikta D.C., Fregly M.J. Effect of chronic treatment with captopril on reactivity of aortic smooth muscle from normotensive and renal hypertensive rats. J. Hypertens. 1:1983;267-275.
19. Kirpichnikov D., Winer N., Sowers J.R. The use of ACE inhibitors on diabetic patients without renal disease. Curr. Diabetes-Rep. 2:2002;21-25.
20. Lemos V.S., Cortes S.F., Silva D.M., Campagnole-Santos M.J., Santos R.A. Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats. Br. J. Pharmacol. 135:2002;1743-1748.
21. Macleod K.M., McNeill J.H. Alpha adrenoceptor mediated responses in aorta from three month streptozotocin diabetic rats. Proc. West. Pharmacol. Soc. 25:1982;245-247.
22. Mancini G.B.J., Henry G.C., Macaya C.B., O'Neill B.J., Pucillo A.L., Carere R.G., Wargovich T.J., Mudra H., Luscher T.F., Klibaner M.I., Haber H.E., Uprichard A.C., Pepine C.J., Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation. 94:1996;258-265.
23. Mullen M.J., Clarkson P., Donald A.E., Thomson H., Thorne S.A., Powe A.J., Furuno T., Bull T., Deanfield J.E. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. J. Am. Coll. Cardiol. 31:1998;1330-1335.
24. Omata K., Kanazawa M., Sato T., Abe F., Saito T., Abe K. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease. Kidney Int. 49:1996;S57-S62.
25. Ozcelikay A.T., Pekiner C., Ari N., Ozturk Y., Ozuari A., Altan V.M. The effect of vanadyl treatment on vascular responsiveness of streptozotocin- diabetic rats. Diabetologia. 37:1994;572-578.
26. Ozturk Y., Altan V.M., Yidizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle function. Pharmacol. Rev. 48:1996;69-112.
27. Qi J.H., Zhang L., Wang J., Wei P.J., Gu P.K., Jin Z.J., Huang M.Z., Wang H.Y. Effects of captopril and enalapril on intracellular Ca2+ in vascular smooth muscle cell. Zhongguo Yaoli Xuebao. 17:1996;142-145.
28. Sand C., Peters S.L., Pfaffendorf M., van Zwieten P.A. Oxidative stress impairs the haemodynamic activity of cardiovascular agents with antioxidant properties. Naunyn-Schmiedeberg's Arch. Pharmacol. 364:2001;454-461.
29. Senses V., Ozyazgan S., Ince E., Tuncdemir M., Kaya F., Ozturk M., Sultuybek G., Akkan A.G. Effect of 5-aminoimidazole-4-carboxamide riboside (AICA-r) on isolated thoracic aorta responses in streptozotocin-diabetic rats. J. Basic Clin. Physiol. Pharmacol. 12:2001;227-248.
30. Uemura S., Matsushita H., Li W., Glassford A.J., Asagami T., Lee K.H., Harrison D.G., Tsao P.S. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88:2001;1291-1298.
31. Van Gilst W.H., de Graeff P.A., Wesseling H., de Langen C.D.J. Reduction of reperfusion arrhythmias in the ischemic isolated heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril and HOE 498. Cardiovasc. Pharmacol. 8:1986;722-728.
32. Vinik A.I., Vinik E. Prevention of the complications of diabetes. Am. J. Manag. Care. 9:2003;S63-S80.
33. Wojakowski W., Gminski J., Siemianowicz K., Goss M., Machalski M. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia. Int. J. Mol. Med. 6:2000;591-594.
34. Zhu Z., Tepel M., Neusser M., Mehring N., Zidek W. Effect of captopril on vasoconstriction and Ca2+ fluxes in aortic smooth muscle. Hypertension. 22:1993;806-811.